Levels of endocannabinoid metabolizing enzymes are not related with BDNF levels in patients with schizophrenia: a case-controlled study
PURPOSE: While the pathogenesis of schizophrenia has yet to be fully clarified, a huge amount of data suggests the involvement of endocannabinoid system and neurotrophic factors in schizophrenia. Nevertheless, only a very limited number of studies have investigated these two systems together. With t...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mesut Çetin
2019-10-01
|
| Col·lecció: | Psychiatry and Clinical Psychopharmacology |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/24750573.2018.1540200 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|